scispace - formally typeset
M

Marc Diederich

Researcher at Seoul National University

Publications -  307
Citations -  20195

Marc Diederich is an academic researcher from Seoul National University. The author has contributed to research in topics: Apoptosis & Programmed cell death. The author has an hindex of 62, co-authored 299 publications receiving 17177 citations. Previous affiliations of Marc Diederich include University of Aberdeen & Metz.

Papers
More filters
Journal ArticleDOI

Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)

Daniel J. Klionsky, +2522 more
- 21 Jan 2016 - 
TL;DR: In this paper, the authors present a set of guidelines for the selection and interpretation of methods for use by investigators who aim to examine macro-autophagy and related processes, as well as for reviewers who need to provide realistic and reasonable critiques of papers that are focused on these processes.
Journal ArticleDOI

Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)

Daniel J. Klionsky, +2983 more
- 08 Feb 2021 - 
TL;DR: In this article, the authors present a set of guidelines for investigators to select and interpret methods to examine autophagy and related processes, and for reviewers to provide realistic and reasonable critiques of reports that are focused on these processes.
Journal ArticleDOI

Chemopreventive and therapeutic effects of curcumin.

TL;DR: Curcumin is described as an anti-tumoral, anti-oxidant and anti-inflammatory agent capable of inducing apoptosis in numerous cellular systems capable of suppression, retardation or inversion of carcinogenesis.
Journal ArticleDOI

Molecular and therapeutic potential and toxicity of valproic acid.

TL;DR: An overview of the different clinical-trials involving VPA and its side effects encountered during treatment as well as its molecular properties are given.
Journal ArticleDOI

The Role of cyclooxygenase-2 in Cell Proliferation and Cell Death in Human Malignancies

TL;DR: The findings prompt us to analyze here the effects of a combination of COX-2 inhibitors together with different clinically used therapeutic strategies in order to further improve the efficiency of future anticancer treatments.